Oncorine

DRUG2 trials

Sponsors

Xinqiao Hospital of Chongqing, Fudan University

Conditions

Hepatocellular CarcinomaMalignant HydrothoraxNon Small Cell Lung Cancer

Phase 1

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Fudan UniversityHepatocellular Carcinoma

Start: 2023-03-01End: 2025-12-30Target: 25Updated: 2023-03-06

Phase 3

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Xinqiao Hospital of ChongqingMalignant Hydrothorax, Non Small Cell Lung Cancer

Start: 2016-10-31End: 2018-12-31Target: 134Updated: 2016-10-21